Golimumab: A novel human anti-TNF-α monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis

Overview of attention for article published in Core Evidence, July 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 83 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Liquid pharmaceutical composition of adalimumab

Grant US-10688187-B2

United States of America

TNF-ALPHA ANTIGEN-BINDING PROTEINS

Application WO-2014114651-A1

World Intellectual Property Organisation (WIPO)

FULL HUMAN ANTI-TNF- ALPHA MONOCLONAL ANTIBODY, PREPARATION METHOD AND USE THEREOF

Application EP-2540743-A4

European Patent Office

FULL HUMAN ANTI-TNF- ALPHA MONOCLONAL ANTIBODY, PREPARATION METHOD AND USE THEREOF

Application EP-2540743-A1

European Patent Office